CA53562-1 - 0x00000000000072DF
Healthy Males & Females
Alphabet
* Stipend may pay up to reflected amount.
Start Date:
November 3, 2026 - 2:00pm
End Date:
December 1, 2026 - 8:45am
Study Details
Study Number: CA53562
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,000.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat lupus and psoriasis.
Route of Administration: Oral
Blood Draws: 36
Study Schedule
Schedule Type: Long Term
Study Length: 17 Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 10/20/2026 |
| Wednesday | 10/21/2026 |
| Tuesday | 10/27/2026 |
| Friday | 10/30/2026 |
| Monday | 11/2/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 10/20/2026 |
| Wednesday | 10/21/2026 |
| Tuesday | 10/27/2026 |
| Friday | 10/30/2026 |
| Monday | 11/2/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Tuesday | 11/3/2026 2:00:00 PM | Friday | 11/20/2026 9:15:00 AM | 1 | Lincoln |
| Return | Tuesday | 12/1/2026 7:30:00 AM | Tuesday | 12/1/2026 8:45:00 AM | 1 | Lincoln |
